$IDRA..$3.77.. has received an orphan drug status for its treatment of diffuse large B-cell lymphoma, according to the U.S. Food and Drug Administration.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.